Literature DB >> 26594315

Understanding melanoma stem cells.

Nicholas Nguyen1, Kasey L Couts1, Yuchun Luo1, Mayumi Fujita2.   

Abstract

Tumors are incredibly diverse and contain many different subpopulations of cells. The cancer stem cell (CSC) subpopulation is responsible for many aspects of tumorigenesis and has been shown to play an important role in melanoma development, progression, drug resistance and metastasis. However, it is becoming clear that tumor cell populations are dynamic and can be influenced by many factors, such as signals from the tumor microenvironment and somatic evolution. This review will present the current understanding of CSCs and the challenges of identifying and characterizing this dynamic cell population. The known characteristics and functions of melanoma stem cells, and the potential for therapeutic targeting of these cells in melanoma, will be discussed.

Entities:  

Keywords:  cancer stem cells; melanoma; melanoma stem cells; targeting cancer stem cells; tumor cell plasticity; tumor heterogeneity; tumor initiating cells

Year:  2015        PMID: 26594315      PMCID: PMC4649940          DOI: 10.2217/mmt.15.4

Source DB:  PubMed          Journal:  Melanoma Manag        ISSN: 2045-0885


  76 in total

Review 1.  The role of stem and circulating cells in cancer metastasis.

Authors:  Ruby Ghadially
Journal:  J Surg Oncol       Date:  2011-05-01       Impact factor: 3.454

2.  CD133+ renal progenitor cells contribute to tumor angiogenesis.

Authors:  Stefania Bruno; Benedetta Bussolati; Cristina Grange; Federica Collino; Manuela Efrem Graziano; Ugo Ferrando; Giovanni Camussi
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

3.  VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth.

Authors:  Natasha Y Frank; Tobias Schatton; Soo Kim; Qian Zhan; Brian J Wilson; Jie Ma; Karim R Saab; Veronika Osherov; Hans R Widlund; Martin Gasser; Ana-Maria Waaga-Gasser; Thomas S Kupper; George F Murphy; Markus H Frank
Journal:  Cancer Res       Date:  2011-01-06       Impact factor: 12.701

4.  Identification of cells initiating human melanomas.

Authors:  Tobias Schatton; George F Murphy; Natasha Y Frank; Kazuhiro Yamaura; Ana Maria Waaga-Gasser; Martin Gasser; Qian Zhan; Stefan Jordan; Lyn M Duncan; Carsten Weishaupt; Robert C Fuhlbrigge; Thomas S Kupper; Mohamed H Sayegh; Markus H Frank
Journal:  Nature       Date:  2008-01-17       Impact factor: 49.962

5.  Systemic spread is an early step in breast cancer.

Authors:  Yves Hüsemann; Jochen B Geigl; Falk Schubert; Piero Musiani; Manfred Meyer; Elke Burghart; Guido Forni; Roland Eils; Tanja Fehm; Gert Riethmüller; Christoph A Klein
Journal:  Cancer Cell       Date:  2008-01       Impact factor: 31.743

6.  Identification of pancreatic cancer stem cells.

Authors:  Chenwei Li; David G Heidt; Piero Dalerba; Charles F Burant; Lanjing Zhang; Volkan Adsay; Max Wicha; Michael F Clarke; Diane M Simeone
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

7.  Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells.

Authors:  David C Taussig; Farideh Miraki-Moud; Fernando Anjos-Afonso; Daniel J Pearce; Kirsty Allen; Christopher Ridler; Debra Lillington; Heather Oakervee; Jamie Cavenagh; Samir G Agrawal; T Andrew Lister; John G Gribben; Dominique Bonnet
Journal:  Blood       Date:  2008-06-03       Impact factor: 22.113

8.  Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas.

Authors:  Arnout G Schepers; Hugo J Snippert; Daniel E Stange; Maaike van den Born; Johan H van Es; Marc van de Wetering; Hans Clevers
Journal:  Science       Date:  2012-08-01       Impact factor: 47.728

9.  Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples.

Authors:  Daniel J Pearce; David Taussig; Catherine Simpson; Kirsty Allen; Ama Z Rohatiner; T Andrew Lister; Dominique Bonnet
Journal:  Stem Cells       Date:  2005 Jun-Jul       Impact factor: 6.277

10.  A restricted cell population propagates glioblastoma growth after chemotherapy.

Authors:  Jian Chen; Yanjiao Li; Tzong-Shiue Yu; Renée M McKay; Dennis K Burns; Steven G Kernie; Luis F Parada
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

View more
  9 in total

1.  CDK1 Interacts with Sox2 and Promotes Tumor Initiation in Human Melanoma.

Authors:  Dinoop Ravindran Menon; Yuchun Luo; John J Arcaroli; Sucai Liu; Lekha Nair KrishnanKutty; Douglas G Osborne; Yang Li; Jenny Mae Samson; Stacey Bagby; Aik-Choon Tan; William A Robinson; Wells A Messersmith; Mayumi Fujita
Journal:  Cancer Res       Date:  2018-10-08       Impact factor: 12.701

Review 2.  Alternative Treatments For Melanoma: Targeting BCL-2 Family Members to De-Bulk and Kill Cancer Stem Cells.

Authors:  Nabanita Mukherjee; Josianna V Schwan; Mayumi Fujita; David A Norris; Yiqun G Shellman
Journal:  J Invest Dermatol       Date:  2015-05-07       Impact factor: 8.551

3.  Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells.

Authors:  Nabanita Mukherjee; Yan Lu; Adam Almeida; Karoline Lambert; Chung-Wai Shiau; Jung-Chen Su; Yuchun Luo; Mayumi Fujita; William A Robinson; Steven E Robinson; David A Norris; Yiqun G Shellman
Journal:  Oncotarget       Date:  2017-07-18

4.  Zebrafish modeling reveals that SPINT1 regulates the aggressiveness of skin cutaneous melanoma and its crosstalk with tumor immune microenvironment.

Authors:  Elena Gómez-Abenza; Sofía Ibáñez-Molero; Diana García-Moreno; Inmaculada Fuentes; Leonard I Zon; Maria C Mione; María L Cayuela; Chiara Gabellini; Victoriano Mulero
Journal:  J Exp Clin Cancer Res       Date:  2019-09-13

Review 5.  Interleukin-8 in Melanoma Pathogenesis, Prognosis and Therapy-An Integrated View into Other Neoplasms and Chemokine Networks.

Authors:  Anca Filimon; Iulia A Preda; Adina F Boloca; Gabriela Negroiu
Journal:  Cells       Date:  2021-12-30       Impact factor: 6.600

6.  Heme Oxygenase-1 Has a Greater Effect on Melanoma Stem Cell Properties Than the Expression of Melanoma-Initiating Cell Markers.

Authors:  Anna Kusienicka; Karolina Bukowska-Strakova; Maciej Cieśla; Witold Norbert Nowak; Iwona Bronisz-Budzyńska; Agnieszka Seretny; Monika Żukowska; Mateusz Jeż; Rościsław Krutyhołowa; Hevidar Taha; Neli Kachamakova-Trojanowska; Halina Waś; Claudine Kieda; Alicja Józkowicz
Journal:  Int J Mol Sci       Date:  2022-03-25       Impact factor: 5.923

7.  Risk Stratification and Clinical Characteristics of Patients with Late Recurrence of Melanoma (>10 Years).

Authors:  Robin Reschke; Konstantin Dumann; Mirjana Ziemer
Journal:  J Clin Med       Date:  2022-04-05       Impact factor: 4.964

8.  BH3 mimetics induce apoptosis independent of DRP-1 in melanoma.

Authors:  Nabanita Mukherjee; Andrew Strosnider; Bay Vagher; Karoline A Lambert; Sarah Slaven; William A Robinson; Carol M Amato; Kasey L Couts; Judson G T Bemis; Jacqueline A Turner; David A Norris; Yiqun G Shellman
Journal:  Cell Death Dis       Date:  2018-09-05       Impact factor: 8.469

9.  Enrichment of Melanoma Stem-Like Cells via Sphere Assays.

Authors:  Nabanita Mukherjee; Karoline A Lambert; David A Norris; Yiqun G Shellman
Journal:  Methods Mol Biol       Date:  2021
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.